MEGAN BENDER: Open Payments
NPI 1639506348 · LAKEWOOD RANCH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,418 in 144 payments from 23 companies in 2025. Trend: 2023 $1,956 · 2024 $3,144 · 2025 $3,418
Food & beverage: $3,411Education: $7
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $655 |
| UCB, Inc. | 11 | $407 |
| GENZYME CORPORATION | 6 | $222 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $222 |
| Regeneron Healthcare Solutions, Inc. | 10 | $217 |
| Janssen Biotech, Inc. | 11 | $194 |
| Novartis Pharmaceuticals Corporation | 7 | $156 |
| PFIZER INC. | 9 | $155 |
| LEO Pharma Inc. | 5 | $150 |
| Janssen Scientific Affairs, LLC | 1 | $149 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, TREMFYA, RINVOQ, ILUMYA, OPZELURA, COSENTYX.
Industry payments across FL — which companies pay providers there.
